Testosterone replacement in the infertile man. Review uri icon

Overview

abstract

  • Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man's health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism treatment. Despite that, patients complaining of infertility or seeking conception are still hindered by the unfavorable effects supplemental T has on testicular function. Consequently, alternative approaches that can stimulate endogenous T production are favored. Selective estrogen receptor modulators, gonadotropins and aromatase inhibitors (AIs) can be successful in restoring serum T levels, preserving fertility, and providing symptomatic relief.

publication date

  • December 1, 2016

Identity

PubMed Central ID

  • PMC5182223

Scopus Document Identifier

  • 85006310600

Digital Object Identifier (DOI)

  • 10.21037/tau.2016.08.03

PubMed ID

  • 28078217

Additional Document Info

volume

  • 5

issue

  • 6